KRAS and pancreatic neoplasm: It is interesting to note that the targeted expression of oncogenic KRAS to CK19-positive epithelial cells in transgenic mice did not cause pancreatic tumors [108], which may suggest that the pancreatic ductal epithelial cells may not be significantly more susceptible to KRAS-induced neoplastic transformation.